Consumer News: What to ask when considering a pre-paid funeral plan

Scammers are cloning trusted voices to push bogus offers

• Scammers are creating fake videos that appear to show consumer advocates like Clark Howard promoting bogus offers.

• If its not posted on the experts official website or verified social pages, dont click or share it.

• Brand-new accounts, misspelled usernames, disabled comments, unknown links, and instant savings claims usually signal a scam.

A new scam is circulating online and it looks way too real. Scammers are using artificial intelligence to generate videos that seem to show trusted consumer adviser Clark Howard promoting products or services. But make no mistake about it, these are not real endorsements.

In at least one AI-generated video, an imitation Clark is shown recommending a tool for finding cheaper car insurance. Viewers at first thought it was the real Clark Howard, as this is the type of advice he often gives, but they soon realized it was 100% fake.

This is part of a growing wave of deepfake where fraudsters use AI-generated faces and voices to trick you into buying something, clicking a link, or giving up personal information.

Practical tips to protect yourself

1. Always verify the source.

If a video claims to be from Clark Howard or any trusted expert, check his/her official website or verified social pages before doing anything. Real and authentic content will always be shared there first.

2. Dont click or share suspicious posts.

Even if the video looks real, be skeptical, especially if its not being shown on the official social media page of the consumer advocate.

Be even more cautious if the video is strongly recommending a product, insurance offer, or deal that seems a little too good to be true.

3. Watch for red flags:

• Unusual claims (like zero fees, instant savings with no proof).
• Links to unknown websites.
• Immediate requests for personal info.
• Comments turned off.

These are all prevalent in the deepfake posts going around right now on social media.

4. Compare with known content.

In the Clark Howard example, its smart to search for the same advice hes giving on his official website and social media channels.

If you cant find it there, its safe to assume its fake.

5. Check the account details.

These fake videos usually come from brand-new social accounts that look real at first glance. Some even have a slight misspelling in an attempt to copy a legitimate source.

Get in the habit of tapping the profile. From there, take a close look at when it was created, how many followers it has, and what other videos have been posted.

A real consumer advocate like Clark Howard will have a long posting history, consistent branding, and verified badges.

The approval marks an expansion of delivery options

By Mark Huffman of ConsumerAffairs

• The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device.

• Lilly says the new pen expands patient choice, with self-pay pricing through LillyDirect starting at $299 per month for the 2.5 mg dose.

• Zepbound remains the top-prescribed injectable obesity medication, with clinical trials showing average weight loss of up to 50 pounds.

Eli Lilly and Company has announced that the U.S. Food and Drug Administration has approved a label expansion for its obesity drug Zepbound, adding a new four-dose, single-patient-use KwikPen designed to deliver a full month of treatment in a single device.

The approval marks an expansion of delivery options for Zepbound (tirzepatide), which is already available in single-dose vials. Lilly said the KwikPen is intended to give patients and healthcare providers more flexibility in choosing a format that best fits individual preferences and circumstances.

Zepbound is the No. 1 prescribed injectable obesity-management medication, helping adults achieve meaningful and clinically proven weight loss, on average, up to 50 pounds as seen in SURMOUNT-5, said Ilya Yuffa, executive vice president and president of Lilly USA and Global Customer Capabilities.

As part of our commitment to supporting people living with obesity in their weight management journey, we are introducing a new option with the Zepbound KwikPen, a device trusted by patients globally and in the United States for other Lilly medicines.

Direct-to-consumer platform

The company is also emphasizing affordability through its direct-to-consumer platform, LillyDirect. Patients with a valid prescription who opt to self-pay through LillyDirect can receive Zepbound in either the KwikPen or single-dose vial, with pricing starting at $299 per month for the 2.5 mg starting dose.

Lilly said more than 1 million patients accessed its treatments through LillyDirect in 2025. The company added that one in three new patients beginning a branded weight management medication last year was prescribed Zepbound self-pay vials, underscoring demand for alternative access models amid ongoing pricing scrutiny in the GLP-1 market.

Lilly said Zepbounds growing use is driven in part by clinical data showing substantial weight loss. In the 72-week SURMOUNT-1 trial, adults taking the 15 mg dose lost an average of 20.9% of their body weight, compared with 3.1% for those on placebo. In the open-label SURMOUNT-5 study, patients taking Zepbound lost an average of 50 pounds, or 20.2% of body weight, compared with 33 pounds, or 13.7%, among those taking injectable Wegovy.

Zepbound is approved for adults with obesity, as well as certain adults who are overweight and have at least one weight-related medical condition, to help reduce excess body weight and maintain weight loss. It is also approved for adults with moderate-to-severe obstructive sleep apnea and obesity to improve OSA symptoms.

Lilly cautions that Zepbound is not for cosmetic weight loss and that individual results may vary. The drug carries a boxed warning about the risk of thyroid tumors, including thyroid cancer.

It should not be used by patients with a personal or family history of medullary thyroid carcinoma or by those with Multiple Endocrine Neoplasia syndrome type 2. Zepbound should also not be used with other tirzepatide-containing products or GLP-1 receptor agonists, and its safety and effectiveness in children have not been established.

The national average price inched up again this week

By Mark Huffman of ConsumerAffairs

• The nations average price of gasoline has risen 1.2 cents over the last week and stands at $2.88 per gallon, according to GasBuddy data compiled from more than 12 million individual price reports covering over 150,000 gas stations across the country.

• The national average is up 2.8 cents from a month ago and is 19.5 cents per gallon lower than a year ago.

• The national average price of diesel rose 6.2 cents in the last week and stands at $3.686 per gallon.

Motorists are seeing gas prices edge higher as rising oil prices and geopolitical tensions add pressure to fuel markets heading into late winter.

According to GasBuddy, the national average price of gasoline climbed 1.2 cents over the past week to $2.88 per gallon. While prices are modestly higher than a month ago, they remain nearly 20 cents below where they stood at this time last year. Diesel prices posted a sharper increase, jumping 6.2 cents to $3.686 per gallon.

Average gasoline prices continue to drift higher as crude oil trades near its highest level since last summer, driven by mounting geopolitical risk premiums tied to escalating tensions between the United States and Iran, Patrick De Haan, head of petroleum analysis at GasBuddy, said in the companys weekly blog.

While there has been no direct disruption to energy infrastructure, markets are increasingly pricing in the possibility of a broader exchange that could threaten supply flows.

Other issues

De Haan noted that beyond geopolitical concerns, domestic supply issues are also contributing to upward price pressure. Refinery outages and disruptions along the Olympic Pipeline have tightened supply in parts of the Pacific Northwest, pushing prices higher in that region. With refinery maintenance season approaching, he warned that the national average could soon test the $3-per-gallon mark as seasonal supply constraints intensify.

Oil markets have been driven largely by renewed tensions in the Middle East, particularly concerns involving Iran and the potential for supply disruptions near the Strait of Hormuz a critical chokepoint for global crude shipments. That risk premium helped lift crude prices over the past week.

In early Monday trading, West Texas Intermediate crude rose 37 cents to $66.85 per barrel, up nearly $4 from the previous Mondays $62.98 settlement. Brent crude also climbed 32 cents to $72.08 per barrel, compared with $67.84 a week earlier.

Giovanni Staunovo, a commodities analyst at UBS, said oil is trading at a multi-month high, supported primarily by geopolitical tensions. New talks between the U.S. and Iran are scheduled later this week. Historically, he noted, risk premiums tend to fade if supply disruptions fail to materialize. Traders are also watching next Sundays OPEC+ Group of Eight meeting for potential policy signals.

Inventories tighten despite balanced supply picture

The latest data from the U.S. Energy Information Administration showed a mixed supply backdrop.

For the week ending February 13, U.S. crude oil inventories fell by 9.0 million barrels and now sit about 5% below the seasonal average. The Strategic Petroleum Reserve rose slightly, increasing by 200,000 barrels to 415.4 million barrels.

Gasoline inventories declined by 3.2 million barrels but remain roughly 3% above the five-year seasonal average. Distillate inventories, which include diesel, fell by 4.6 million barrels and are about 5% below the five-year average.

Refinery utilization increased 1.6 percentage points to 91.0%, while implied gasoline demand a proxy for retail demand rose by 448,000 barrels per day to 8.749 million barrels per day.

Despite relatively balanced global supply fundamentals, the drawdowns in crude and distillate stocks, combined with rising refinery maintenance, could limit near-term relief at the pump.

Regional price gaps persist

While the national average stands at $2.88 per gallon, prices vary widely across the country.

The most common price motorists encounter is $2.69 per gallon, down 10 cents from last week.

The median U.S. gas price is $2.75 per gallon, about 13 cents lower than the national average.

The top 10% of stations are charging an average of $4.36 per gallon, while the bottom 10% average just $2.29 per gallon.

Oklahoma ($2.29), Arkansas ($2.40), and Louisiana ($2.42) currently boast the lowest statewide averages. At the other end of the spectrum, California ($4.55), Hawaii ($4.31), and Washington ($4.23) have the highest prices.

Among weekly movers, Oregon saw the largest increase, with prices rising 17.2 cents, followed by Washington (+14.6 cents) and Minnesota (+13.3 cents). Michigan posted a notable decline of 12.4 cents, while Ohio rose 10.7 cents.

With oil hovering at multi-month highs and refinery maintenance season approaching, analysts say drivers should be prepared for the possibility of further incremental increases in the weeks ahead.

A consumer complaint led to the recall

By Mark Huffman of ConsumerAffairs

• Rosina Food Products recalls 9,462 pounds of frozen meatballs over possible metal contamination.

• Affected Bremer Family Size Italian Style Meatballs were sold at Aldi stores nationwide.

• No injuries have been reported, but consumers are urged not to eat the product.

Rosina Food Products, Inc., is recalling approximately 9,462 pounds of ready-to-eat frozen meatball products that may be contaminated with metal fragments, according to the U.S. Department of Agricultures Food Safety and Inspection Service (FSIS).

The recall involves fully cooked frozen Bremer Family Size Italian Style Meatballs produced on July 30, 2025. The affected items were sold in 32-ounce printed poly film bags labeled as containing about 64 meatballs per package.

The packages bear a BEST BY date of Oct. 30, 2026, along with timestamps between 17:08 and 18:20 printed on the back of the label.

The recalled products display establishment number EST. 4286B inside the USDA mark of inspection. They were distributed to Aldi supermarket locations nationwide and have a 15-month shelf life.

Consumer complaint triggered the recall

The issue came to light after FSIS received a consumer complaint reporting metal fragments found in the meatballs. There have been no confirmed reports of injuries associated with the product. However, officials advise anyone concerned about a possible injury to contact a healthcare provider.

FSIS expressed concern that some of the recalled meatballs may still be in consumers refrigerators or freezers. Shoppers who purchased the product are urged not to consume it and to either discard it or return it to the place of purchase.

The agency said it routinely conducts recall effectiveness checks to ensure that companies notify customers and remove affected products from commerce. Retail distribution lists will be posted on the FSIS website as they become available.

Consumers with questions about the recall can contact Rosina Food Products customer service line at 1-888-767-4621 or by email at CService@rosina.com.

Consumers with food safety questions may call the USDA Meat and Poultry Hotline at 888-674-6854 or email MPHotline@usda.gov. Food safety concerns can also be reported through the USDAs Electronic Consumer Complaint Monitoring System, available online 24 hours a day.